Non-Segmental Vitiligo

New York and Suzhou, China, September 8, 2026 Accro Bioscience has announced a major clinical development milestone for AC-201,...

North Chicago, Ill., July 29, 2026 AbbVie announced that the European Commission (EC) has approved RINVOQ® (upadacitinib) for the...

Beijing, July 16, 2026 InnoCare Pharma announced that the Phase II portion of its adaptive Phase II/III clinical trial...